-
US drops Reflecting Pool case, admits damage due to botched renovation
-
Warsaw and Kyiv exhume Volyn victims at centre of diplomatic quarrel
-
Russian attacks on Kyiv kill 9, wound more than two dozen
-
India PM Modi says he forgives protesters who abused him
-
Injured Australian swim star O'Callaghan pulls out of PanPacs
-
Veteran Wallabies playmaker Quade Cooper eyes World Cup comeback
-
California lifeguards wiped out from extreme weather
-
FIFA scraps private investment plan after backlash
-
FIFA scraps private investment plan after backlash: Infantino
-
US plans steep water cuts for southwest amid Colorado River crisis
-
South Africa's WAFCON hopes hang in the balance after dramatic draw
-
Nakashima ousts top seed de Minaur, Osaka advances at Washington
-
Hunter Bell cruises to Commonwealth gold, Pathirage stuns javelin stars
-
Nakashima ousts top seed de Minaur and Osaka advances at Washington
-
Amazon surges as US stocks shrug off bond yield worries
-
Nakashima ousts defending champion de Minaur to reach Washington semis
-
Google rolls back new satellite image AI tool after backlash
-
Magaia salvages last-gasp WAFCON draw for South Africa
-
Ryu leads in bid for third straight major at women's British Open
-
Forever chemicals and pesticides under Trump: what to know
-
Fire-hit France region 'coming up for air' as main blaze calms
-
US announces steep water cuts for three states amid Colorado River crisis
-
Wembanyama to get signature shoe in Nike contract extension: reports
-
EU grapples with migrant crisis in Spain's N. Africa enclave
-
Oil giants report blowout profits on war, warn high gas prices could persist
-
Hungary to shut nuclear plant as heatwave hits central Europe
-
Google launches new satellite image AI tool, alarming researchers
-
Strengthening El Nino 'adding fuel to a planet already on fire': UN chief
-
Eddie Howe resigns as Newcastle boss to 'recharge'
-
Tech-fuelled rally fizzles as oil prices rise
-
High winds hamper firefighting efforts in western Turkey
-
Chelsea's Mudryk cleared to play after doping ban appeal
-
Howe resigns as Newcastle boss
-
A side of oysters for France's flat-out firefighters
-
Full-scale tour will benefit All Blacks, says coach Rennie
-
England cricket chief Key refuses to rule out Stokes return
-
US Fed dissenters call for rate hikes over sustained inflation
-
New blazes in Greece as strong winds hamper firefighting
-
Trump and far-right seize on Spanish migration crisis
-
Springboks star Feinberg-Mngomezulu back for Argentina Test
-
Hamas agrees to disarm under Trump plan
-
Shops closed, businesses quiet as Spain's Ceuta faces migrant surge
-
French, Italian winegrowers face earliest ever harvest
-
Chelsea fined £10mn, handed suspended transfer ban for breaching agent rules
-
Alarm over climate-linked low level of German waterways
-
Residents defend Spain’s ancient 'El Abuelo' tree from flames
-
UK court rejects challenge against new Chinese embassy in London
-
Forever chemicals and pesticides: what to know
-
New York sues online prediction markets giant Kalshi
-
Spaniard Santi Denia takes over as Czech Republic coach
Ozempic Meals? Restaurants shrink portions to match bite-sized hunger
A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.
Then she started Ozempic.
She lost her appetite -- "my desire for cocktails and desserts and anything sweet" -- and also more than 20 pounds (9.1 kilograms) in less than two months.
But "I still wanted to maintain my social lifestyle, and I still wanted to be included in dinners," the Swedish 41-year-old who works in the tequila industry told AFP.
One of her favorite restaurants, Manhattan's Le Petit Village, made that easier: it's among the dining establishments in the city offering smaller portions at lower prices, as the prevalence of medications that reduce hunger like Ozempic grows.
The West Village restaurant decided to shrink a corner of its brunch menu, including French toast and a smoked salmon tartine, not least to accommodate diners on GLP-1s who want to go out but can't eat much.
Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are increasingly popular for weight loss, according to a November poll by the non-profit health policy tracker KFF.
And one in five say they've taken the medications whose brand names include Ozempic and Wegovy -- which are also prescribed to manage chronic conditions like diabetes -- at some point.
On Monday, Danish pharmaceutical giant Novo Nordisk announced US authorities had approved Wegovy to be administered in pill form for weight loss, potentially making it even more accessible.
Some in the restaurant industry are taking note.
"I was going out and seeing people eat a lot less and take one bite of their food and one sip of their drink and that was it," said Aristotle Hatzigeorgiou, who owns Clinton Hall, which has five locations across New York.
And on top of that, much of the dishes his kitchens prepared ended up in the trash -- "a mass amount of waste," he said.
So he developed the "teeny-weeny mini meal" -- for $8, diners get a bite-sized burger, a small portion of fries and their choice of a 3-oz beer, martini or glass of wine.
It's a stark contrast to some of the beer hall's other offerings, which include a "doughnut grilled cheese" and a "fondue burger" (they are what they sound like.)
But the mini-meal has proven a hit, Hatzigeorgiou said, not only for those dropping weight but for those cutting costs.
"I think people are definitely strapped with rents going up and inflation," said the restaurant owner.
Offering "a cheaper option to come out," he said, has "been working."
- 'Vast human experiment' -
For now, GLP-1s for weight loss purposes remain too expensive for many Americans.
But experts expect that will shift; even US President Donald Trump has promised affordable options.
And researchers are starting to examine how wider GLP-1 use is shaking cultural connections to food.
"Food is your enemy, instead of your great pleasure in life? I mean, that's very different," Marion Nestle, a professor emerita of nutrition at New York University, told AFP in an interview. "I think the jury is out on all of it."
Side effects of GLP-1s can include unpleasant gastrointestinal issues, but for some people, Nestle said, the medications have proven "miraculous."
The nutritionist said it's far too soon to have a grasp on long-term impact, physiologically or socioculturally: "It's a vast human experiment."
Axmacher told AFP she's taken Ozempic on and off.
When she first decided to take a break, "I was ready to feel like I could enjoy life a little bit more again."
"I do enjoy the sense of hunger and satisfaction when I get to eat something I'm in the mood for," she said, adding that on Ozempic, "I missed that."
But using the medication also helped her develop positive and sustainable habits, she said: Axmacher cut down on alcohol, exercised more, and focused on eating enough protein.
Ozempic or not, a trend of smaller restaurant dishes in the wake of America's 1990s-2000s Super Size Era can only be positive, Nestle said.
Le Petit Village management told AFP they're considering expanding their menu of half-sized portions to dinner service, and Clinton Hall is working on developing a mini-meal featuring chicken.
Some customers, Hatzigeorgiou said, have noted that "this is what meals used to look like."
"We think it's something different, but maybe it's not so different," he said with a chuckle. "Maybe it's the right-sized meal."
D.Schaer--VB